tiprankstipranks
Trending News
More News >
Sinco Pharmaceuticals Holdings Ltd. (HK:6833)
:6833
Hong Kong Market

Sinco Pharmaceuticals Holdings Ltd. (6833) Income Statement

Compare
0 Followers

Sinco Pharmaceuticals Holdings Ltd. Income Statement

Last quarter (Q2 2025), Sinco Pharmaceuticals Holdings Ltd.'s total revenue was ¥1.20B, an increase of 9.70% from the same quarter last year. In Q2, Sinco Pharmaceuticals Holdings Ltd.'s net income was ¥24.39M. See Sinco Pharmaceuticals Holdings Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 2.82B¥ 2.54B¥ 2.27B¥ 2.02B¥ 2.05B
Gross Profit
¥ 299.94M¥ 323.28M¥ 305.87M¥ 364.95M¥ 273.83M
Operating Expenses
¥ 205.00M¥ 215.11M¥ 215.91M¥ 198.56M¥ 130.85M
Depreciation and Amortization
¥ 18.66M¥ 16.32M¥ 7.79M¥ 5.14M¥ 8.26M
EBITDA
¥ 132.60M¥ 126.01M¥ 109.01M¥ 197.69M¥ 152.05M
Operating Income
¥ 94.94M¥ 108.17M¥ 89.95M¥ 166.39M¥ 142.98M
Other Income/Expenses
¥ 3.98M¥ -8.29M¥ 9.34M¥ 993.00K¥ -7.02M
Pretax Income
¥ 98.92M¥ 99.88M¥ 99.29M¥ 167.39M¥ 135.96M
Net Income
¥ 42.05M¥ 42.35M¥ 69.46M¥ 135.08M¥ 118.14M
Per Share Metrics
Basic EPS
¥ 0.02¥ 0.02¥ 0.03¥ 0.08¥ 0.07
Diluted EPS
¥ 0.02¥ 0.02¥ 0.03¥ 0.08¥ 0.07
Weighted Average Shares Outstanding
2.10B 2.03B 2.03B 1.74B 1.69B
Weighted Average Shares Outstanding (Diluted)
2.03B 2.03B 2.03B 1.74B 1.69B
Currency in CNY

Sinco Pharmaceuticals Holdings Ltd. Earnings and Revenue History